Purpose: This study aimed to compare the safety and effectiveness of intraocular pressure reduction between micropulse transscleral cyclophotocoagulation and “slow cook” transscleral ...

I’m writing to share about a recent eye procedure I had that is relevant to Ohio Senate Bill 36, the primary eye care modernization bill our policymakers are currently debating. I underwent a ...

MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...

TO SEE THINGS THE WAY OF THE OPTOMETRISTS OR THE OPHTHALMOLOGISTS AT THE STATEHOUSE. IT IS A PUBLIC POLICY WAR, LARGELY INVISIBLE TO PATIENTS OR THE PUBLIC. BUT EYE DOCTORS HAVE BEEN LOCKED IN AN ...

MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...

Dr. Jamie Renbarger has joined Parkview Health as associate chief, research and precision health, and will lead Parkview as it grows its capabilities in genomic-supported research and health care.

Background/aims This work aims to clarify whether micropulse transscleral cyclophotocoagulation (MPCPC) is gentler in terms of postoperative inflammation and is better tolerated compared with ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager ™ DSLT, the ...

Alcon has announced the US release of its Voyager direct selective laser trabeculoplasty (DSLT) platform, with a launch event scheduled for the American Glaucoma Society annual meeting later in ...

Iridex Corporation announced the publication of a significant peer-reviewed study in Ophthalmology Therapy, demonstrating the long-term safety and efficacy of MicroPulse Transscleral Laser Therapy ...